NET PROFIT (x1000 SEK)
EMPLOYEES
Acesion Pharma ApS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-86,124
|
-83,112
|
-90,036 |
| Total assets |
178,835
|
247,053
|
79,599 |
| Current assets |
176,641
|
244,316
|
79,483 |
| Current liabilities |
28,858
|
31,416
|
17,537 |
| Equity capital |
138,026
|
194,736
|
34,394 |
| - share capital |
177,437
|
171,568
|
105,496 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
77.2%
|
78.8%
|
43.2% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
612.1%
|
777.7%
|
453.2% |
| Return on equity (ROE) |
-62.4%
|
-42.7%
|
-261.8% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.